As of 2024-09-13, the Relative Valuation of Neurocrine Biosciences Inc (NBIX) is 144.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 121.28 USD, the upside of Neurocrine Biosciences Inc based on Relative Valuation is 19.4%.
The range of the Relative Valuation is 96.32 - 206.31 USD.
| Range | Selected | |
| Trailing P/E multiples | 40.2x - 61.4x | 56.7x |
| Forward P/E multiples | 31.9x - 38.7x | 32.9x |
| Fair Price | 96.32 - 206.31 | 144.84 |
| Upside | -20.6% - 70.1% | 19.4% |
| Date | P/E |
| 2024-09-12 | 36.11 |
| 2024-09-11 | 36.16 |
| 2024-09-10 | 35.46 |
| 2024-09-09 | 35.91 |
| 2024-09-06 | 35.77 |
| 2024-09-05 | 36.08 |
| 2024-09-04 | 36.48 |
| 2024-09-03 | 37.24 |
| 2024-08-30 | 37.83 |
| 2024-08-29 | 38.23 |
| 2024-08-28 | 36.84 |
| 2024-08-27 | 45.41 |
| 2024-08-26 | 45.33 |
| 2024-08-23 | 45.49 |
| 2024-08-22 | 45.42 |
| 2024-08-21 | 44.92 |
| 2024-08-20 | 44.53 |
| 2024-08-19 | 44.13 |
| 2024-08-16 | 43.17 |
| 2024-08-15 | 43.99 |
| 2024-08-14 | 43.67 |
| 2024-08-13 | 44.86 |
| 2024-08-12 | 43.85 |
| 2024-08-09 | 43.86 |
| 2024-08-08 | 43.68 |
| 2024-08-07 | 42.91 |
| 2024-08-06 | 43.35 |
| 2024-08-05 | 43.97 |
| 2024-08-02 | 45.59 |
| 2024-08-01 | 45.59 |
| 2024-07-31 | 42.15 |
| 2024-07-30 | 42.03 |
| 2024-07-29 | 43.24 |
| 2024-07-26 | 43.70 |
| 2024-07-25 | 43.49 |
| 2024-07-24 | 43.43 |
| 2024-07-23 | 43.30 |
| 2024-07-22 | 43.25 |
| 2024-07-19 | 43.37 |
| 2024-07-18 | 42.91 |
| 2024-07-17 | 43.06 |
| 2024-07-16 | 43.90 |
| 2024-07-15 | 43.90 |
| 2024-07-12 | 43.89 |
| 2024-07-11 | 43.61 |
| 2024-07-10 | 43.80 |
| 2024-07-09 | 42.66 |
| 2024-07-08 | 42.34 |
| 2024-07-05 | 41.40 |
| 2024-07-03 | 41.15 |